Financials
- Fiscal year
- 2025
- Total assets
- €2.4m
- Loss
- -€124,683
- Solvency
- 0.7%
Total assets▲ 94.2%
Net result
20182025
EXTRAPHARM HUY
ActiveSummary
The annual accounts of EXTRAPHARM HUY for fiscal year 2025 show a net loss of 88% of the equity at the start of that year. The 2025 annual accounts show equity of €17,633 and a net result of -€124,683. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 13% of 4,922 sector peers (NACE 47, fiscal year 2025). The company has been active since 2012 and the Belgian State Gazette contains no insolvency or warning signals. The computed 12-month bankruptcy probability is 1.2% (low).
Overview
Activity
Retail sale of pharmaceutical products
NACE 47730
#6 company by total assets in Huy, Wholesale and retail trade sector1 site
Size
€2.4mtotal assets 2025
- Staff
- 4.6 FTE
- Equity
- €17,633
- Loss
- -€124,683
Structure
- Parent
- VSF MANAGEMENT · 100%
- Board
- 1 member
Accounts 79 days early1 of 11 deeds read
Why 53Capped at 59: a net loss of at least half of total assets or of the equity at the start of the financial year- Equity €17,633 (0.7% of total assets)- Loss of €124,683 (FY 2025)- Sector Retail trade (NACE 47)+ Founded in 2012Show the evidence
Checked score
Score 2025
53
/ 100
Fair
Probability in this band: 1.5% to 4.2%
Financially better than 20% of its sector peers (NACE 47, micro)
A net loss of at least half of total assets or of the equity at the start of the financial year caps the score at 59. Every signal that weighs is under Signals.
Financial strength · tick = 2024
Weak
Solvency
26-10
equity 0.7% of total assets
Liquidity
38-4
short-term debt 42.3% · cash 6.3%
Profitability
18-61
return on assets -5.1%
Bankruptcy probability, 12 months
1.2%
Low
0%0.5%1.5%4%10%≥ 25%
About 1 in 100 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
11-2024: 0.4%lowest value
12-2024: 0.4%● unchanged vs 11-2024lowest value
01-2025: 0.4%● unchanged vs 12-2024lowest value
02-2025: 0.4%● unchanged vs 01-2025
03-2025: 0.4%● unchanged vs 02-2025
04-2025: 0.5%▲ +0.1 percentage points vs 03-2025
05-2025: 0.5%● unchanged vs 04-2025
06-2025: 0.4%▼ -0.1 percentage points vs 05-2025
07-2025: 0.4%● unchanged vs 06-2025
08-2025: 0.4%● unchanged vs 07-2025
09-2025: 0.4%● unchanged vs 08-2025
10-2025: 0.4%● unchanged vs 09-2025
11-2025: 0.4%● unchanged vs 10-2025
12-2025: 0.4%● unchanged vs 11-2025
01-2026: 0.4%● unchanged vs 12-2025
02-2026: 0.5%▲ +0.1 percentage points vs 01-2026
03-2026: 0.4%▼ -0.1 percentage points vs 02-2026
04-2026: 0.5%▲ +0.1 percentage points vs 03-2026
05-2026: 0.5%● unchanged vs 04-2026
06-2026: 1.2%▲ +0.7 percentage points vs 05-2026highest value
07-2026: 1.2%● unchanged vs 06-2026highest value
08-2026: 1.2%● unchanged vs 07-2026highest value
09-2026: 1.2%● unchanged vs 08-2026highest value
10-2026: 1.2%● unchanged vs 09-2026highest value
Credit up to €500 at 30 days only on tighter terms
Net loss of at least half of total assets or of the equity at the start of the financial year.
Liquidity short (current ratio 0.69 against 0.96 in 2024; short-term debt: 42.3% and cash: 6.3% of total assets), and 99.3% of the assets are financed with debt.
How it is calculated
The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 19% on solvency, 35% on liquidity, 21% on profitability and 6% on growth.
The bankruptcy probability was computed on 06-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Six signals.
−lowers risk+raises risk○neutral
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 13% of 4922 sector peers (2025).
NBB · sector comparisonPosition among 4922 sector peers
Solvency
better than 13%
← weakest
strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 13-05-2026, 79 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
79 days early
2024
80 days early
2023
79 days early
2022
76 days early
2021
82 days early
2020
74 days early
2019
73 days early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 78 days before the deadline; the sector median for financial year 2024 is on the deadline day, and 47% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 13 May (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven monthsPosition in the running window
07-10-2026 today31-12-2026 close31-07-2027 deadline
- Permanent representatives: FIEY Roel and VAN…Resignation: VSF Management SRL (administrateur…
- Annual accounts filedfiscal year 2025 · full…
- Annual accounts filedfiscal year 2024 · full…
Key points
- Caution: Equity fell in 2025from €142,316 to €17,633 ▼ 87.6% View
- Caution: Among the weakest 10% on net resultsector median €41,027 · 4,922 companies -€124,683 View
- Positive: Always filed on timeaccounts within the deadline every year 8 years View
- Controlled by VSF MANAGEMENT 100% View
- New directorlatest change 07-08-2026 · 1 in office 1 joined View
By topic
Board & ownership
- Board
- 1 member
- Parent
- VSF MANAGEMENT · 100%
Go to Board & ownership
Timeline
- Events
- 14
- Since
- 2017
- Next accounts
- by 31-07-2027
- 13-05-2024Annual accounts filed
- 31-12-2023Highest result since 2018
- 16-05-2023Annual accounts filed
Company details
- Sites
- 1
- Legal form
- Private limited company
- Activity
- Retail sale of pharmaceutical productsNACE 47730
- Founded
- 04-12-2012
- Year ends
- 31-12
- Peppol
- Reachable for e-invoices
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.